Heidi Olzscha is a principal investigator at the Institute of Physiological Chemistry, Medical Faculty, Martin Luther University of Halle-Wittenberg, Germany.
She studied Biochemistry and Molecular Biology at the University of Hamburg, Germany, and did her diploma thesis at the University Hospital Hamburg-Eppendorf at the Institute of Clinical Chemistry.
She received her PhD degree in Biochemistry from the Ludwig Maximilian University in Munich, where she did her PhD studies at the Max Planck Institute of Biochemistry on protein folding, misfolding and neurodegenerative diseases.
She worked then as an EMBO long-term Fellow on the influence of histone deacetylases on protein quality control mechanisms at the University of Oxford, Medical Science Division, UK.
She became a Fulford Junior Research Fellow in Medicine at Somerville College, Oxford, and continued with her work during this time.
From 2016 to 2018, she studied protein citrullination and its influence on rheumatoid arthritis as a Celgene Fellow and was awarded the title “associated Fellow of the Higher Education Academy” (AFHEA) at the University of Oxford.
In 2018, she established her own group at the Institute of Physiological Chemistry in Halle, Germany, working on protein quality mechanisms and posttranslational modifications including acetylation and citrullination.